---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-156073"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2023-05-30T23:59:59+00:00"
generated_at: "2026-06-14T11:18:38.799403+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Vaccinex receives Nasdaq delisting notice for failing to meet $2.5M equity minimum

## Summary
- Stockholders' equity $2.4M as of March 31, 2023; below Nasdaq's $2.5M minimum.
- Company has 45 days (until July 9, 2023) to submit a compliance plan to regain compliance.
- If plan accepted, extension to Nov 21, 2023 possible; otherwise delisting may occur.
- Company plans to submit plan and pursue capital raising, including recent private placement.

## SEC filing metadata
- accession: 0001193125-23-156073
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2023-05-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312523156073/0001193125-23-156073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312523156073/d479290d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-156073
- JSON: https://secwatch.observer/filing/0001193125-23-156073.json
- Plain text: https://secwatch.observer/filing/0001193125-23-156073.txt

## Key facts
- Listing & Compliance Notices
  VACCINEX, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: completed fiscal years (the “Alternative Standards”). The Notice noted that the Company’s Form 10-Q for the period ended March 31, 2023 disclosed stockholders’ equity of $2.4 million as of March 31, 2023 and that, as of May 24, 2023, the Company did not meet the Alternative Standards. The Notice has no immediate effect on the Company’s listing on the Nasdaq
  evidence_url: https://www.sec.gov/Archives/edgar/data/1205922/000119312523156073/0001193125-23-156073-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.